可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q. produced exclusively in adipocytes[J]. J Biol Chem, 1995, 270(45):26746-26749.
[2]Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity[J]. J Biol Chem, 1996, 271(18):10697-10703.
[3]Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity[J]. J Biol Chem, 2004, 279(13):12152-12162.
[4]Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase[J].Nat Med, 2002, 8(11):1288-1295.
[5]Tomas E, Tsao TS, Saha AK, et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation[J]. Proc Natl Acad Sci U S A, 2002, 99(25):16309-16313.
[6]Chen H, Montagnani M, Funahashi T, et al. Adiponectin stimulates production of nitric oxide in vascular endothelial cells[J]. J Biol Chem, 2003, 278(45):45021-45026.
[7]Kobayashi H, Ouchi N, Kihara S, et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin[J]. Circ Res, 2004, 94(4):e27-e31.
[8]Wu X, Mahadev K, Fuchsel L, et al. Adiponectin suppresses IkappaB kinase activation induced by tumor necrosis factor-alpha or high glucose in endothelial cells: role of cAMP and AMP kinase signaling[J]. Am J Physiol Endocrinol Metab, 2007, 293(6):E1836-E1844.
[9]Rodriguez A, Catalan V, Becerril S, et al. Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats[J]. Life Sci, 2008, 83(15-16):540-549.
[10]Deng G, Long Y, Yu YR, et al. Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway[J]. Int J Obes (Lond), 2010, 34(1):165-171.
[11]Shibata R, Sato K, Pimentel DR, et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms[J]. Nat Med, 2005, 11(10):1096-1103.
[12]Gonon AT, Widegren U, Bulhak A, et al. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide[J]. Cardiovasc Res, 2008, 78(1):116-122.
[13]Tao L, Gao E, Jiao X, et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress[J]. Circulation, 2007, 115(11):1408-1416.
[14]Li R, Xu M, Wang X, et al. Reduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance[J]. J Mol Cell Cardiol, 2010, 49(3):508-515.
[15]Hada Y, Yamauchi T, Waki H, et al. Selective purification and characterization of adiponectin multimerspecies from human plasma[J]. Biochem Biophys Res Commun, 2007, 356(2):487-493.
[16]Nakano Y, Shoji A, Arakawa A, et al. Adiponectin does not bind to gelatin - A new and easy way to purify HMW adiponectin from human plasma[J]. J Lipid Res, 2009, 51:210-215.
[17]Tanita T, Miyakoshi H, Nakano Y. Performance of ELISA for specific measurement of high-molecular-weight (HMW) adiponectin.[J]. J Immunol Methods, 2008, 333(1-2):139-146.
[18]Nakano Y, Tajima S, Yoshimi A, et al. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin[J]. J Lipid Res, 2006, 47(7):1572-1582.